IL-8 expression in malignant melanoma: Implications in growth and metastasis

Histology and Histopathology

Volumn 15, Issue 3, 2000, Pages 843-849

  Singh, R K ^a   Varney, M L ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

IL 8; Melanoma; Metastasis

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; NERVE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; DISEASE COURSE; MELANOMA; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PHENOTYPE; PROTEIN EXPRESSION; REVIEW; STROMA CELL; TUMOR CELL;

ANIMALS; HUMANS; INTERLEUKIN-8; MELANOMA; NEOPLASM METASTASIS;

EID: 0033913570     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Type-I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells
2. Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines
3. Surgical decisions regarding lymph node dissection for stage I melanoma patients: Pros and cons of immediate vs. delayed lymphadenectomy
4. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: Evidence for a dominant phenotype
5. Neoplasms: Malignant melanona.
6. Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor
7. Molecular characterization of the interleukin-8 receptor
8. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22
9. Results of adjuvant interferon study in WHO melanoma programme
10. Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2
11. Tumour progression and the nature of cancer
12. A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma
13. Critical factors in the biology of human cancer metastasis: Twenty-eighth GHA Clowes Memorial Award lecture
14. Human melanoma cells produce interleukin-8 which functions as an autocrine growth factor
15. The epidemiology of cutaneous malignant melanoma: Aetiology and European data
16. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice
17. Interleukin-8 and neutrophil activation in acute pancreatitis
18. Lessons from tumor progression: The invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent
19. IL-2 up-regulates but IFN-gamma suppresses IL-8 expression in human monocytes
20. Intertumoral heterogeneity of receptor-tyrosine kinases expression in human melanoma cell lines with different metastatic capabilities
21. Molecular correlates in the progression of normal melanocytes to melanomas
22. Resistance to IL-1 anti-proliferative effect, accompanied by characteristics of advanced melanoma, permits invasion of human melanoma cells in vitro, but not metastasis in the nude mouse
23. Toward the primary prevention of cancer
24. In vivo human melanoma cytokine production: Inverse correlation of GM-CSF production with tumor depth
25. In vitro properties of human melanoma cells metastatic in nude mice
26. Human melanoma: Development and progression
27. Biology of tumor progression in human melanocytes
28. Structure and functional expression of a human interleukin-8 receptor
29. Tumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypes
30. A receptor for the malarial parasite Plasmodium vivax: The erythrocyte chemokine receptor
31. Clinical responses of patients with malignant skin neoplasia to intralesional treatment with three types of interferons (alpha and beta)
32. Carcinoma cells express IL-8 and the IL-8 receptor: Their inhibition attenuates the growth of carcinoma cells
33. IL-1 and TNF-alpha induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line
34. Growth dominance of the metastatic cancer cell: Cellular and molecular aspects
35. Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Malignant melanoma as a paradigm
36. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas
37. Interleukin-8 as a macrophage-derived mediator of angiogenesis
38. Trends in melanoma incidence in the U.S.
39. Cytokines in human melanoma cells: Synthesis, autocrine stimulation and regulatory functions--An overview
40. Cancer statistics
41. The current rapid increase in incidence of mortality from malignant melanoma in developed societies
42. Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts
43. Interferon system defects in human malignant melanoma
44. Interleukin 8 and MCAF: Novel inflammatory cytokines inducible by IL 1 and TNF
45. Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells
46. Mechanisms of organ selective tumour growth by bloodborne cancer cells
47. Cloning of complementary DNA encoding a functional human interleukin-8 receptor
48. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis
49. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis
50. Gene expression, cellular diversification and tumor progression to the metastatic phenotype
51. IFN-gamma selectively inhibits lipopolysaccharide-inducible JE/monocyte chemoattractant protein-1 and KC/GRO/melanoma growth-stimulating activity gene gene expression in mouse peritoneal macrophages
52. Downregulation of interleukin 8 gene expression in human fibroblasts: Unique mechanism of transcriptional inhibition by interferon
53. Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-kappa B site
54. Properties of the novel proinflammatory supergene 'intercrine' cytokine family
55. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor
56. Autoregulation of MeWo metastatic melanoma cell growth: Characterization of intracellular (FGF, MGSA) and secreted (PDGF) growth factors
57. The pathogenic role of growth factors in melanoma
58. Malignant melanoma: Perspectives on incidence and its effects on awareness, diagnosis, and treatment
59. The incidence of malignant melanoma in the United States: Issues as we approach the 21st century
60. Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors
61. An estimate of the incidence of malignant melanoma in the United States. Based on a survey of members of the American Academy of Dermatology
62. Metastatic potential of human melanoma cells in nude mice--Characterisation of phenotype, cytokine secretion and tumour-associated antigens
63. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor
64. Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumour load
65. Interferon-alpha and interferon-gamma down-regulate the production of interleukin-8 and ENA-78 in human monocytes
66. Systemic treatment of metastatic malignant melanoma
67. Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells
68. Heterogeneity of cytokine and growth factor gene expression in human melanoma cells with different metastatic potentials
69. Expression of interleukin-8 correlates with the metastatic potential of human melanoma cells in nude mice
70. Regulation of interleukin 8 expression in human malignant melanoma cells
71. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma
72. Interleukin-8. A corneal factor that induces neovascularization
73. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer
74. Induction of curculating IL-1 receptor antagonist by IFN treatment
75. Interleukin-1 production in tumor cells of human melanoma surgical specimens
76. Serum levels of cytokines in patients with colorectal cancer: Possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis
77. Interaction of interferons with skin reactive cytokines: From interleukin-1 to interleukin-8
78. Intralesional interferon-alpha therapy in advanced malignant melanoma
79. Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8
80. Expression and secretion of leukocyte chemotactic cytokines by normal human melanocytes and melanoma cells